CoChat

MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A

Open access
Li, Huiling, Li, Xiaoling, Ge, Xiaolu, Jia, Liqing, Zhang, Zhezhe, Fang, Renpeng, Yang, Jing, Liu, Jianpin, Peng, Shuping, Zhou, Ming, Xiang, Juanjuan, Zeng, Zhaoyang, Zhou, Wen, Xiong, Wei, Xiao, Gaoming, Fang, Li, Li, Gui-yuan, Li, Zheng · 2016 · Oncotarget
Cited by 35

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

// Huiling Li 1, 2 , Xiaoling Li 2 , Xiaolu Ge 2 , Liqing Jia 2 , Zhezhe Zhang 2 , Renpeng Fang 4 , Jing Yang 2 , Jianpin Liu 3 , Shuping Peng 2 , Ming Zhou 2 , Juanjuan Xiang 2 , Zhaoyang Zeng 2 , Wen Zhou 2 , Wei Xiong 2 , Gaoming Xiao 1 , Li Fang 1 , Gui-yuan Li 1, 2 , Zheng Li 1, 2, 3 1 Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China 2 The Key Laboratory of Carcinogenesis of The Chinese Ministry of Health and The Key Laboratory of Carcinogenesis and Cancer Invasion of The Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, China 3 High Resolution Mass Spectrometry Laboratory of Advanced Research Center, Central South University, Changsha, China 4 Xiangya School of Medicine, Central South University, Changsha, China Correspondence to: Zheng Li, email: lizheng@csu.edu.cn Keywords: nasopharyngeal carcinoma, miR-34b-3, miR449a, LC-MS/MS, lactate dehydrogenase A(LDHA) Received: January 19, 2016 Accepted: July 06, 2016 Published: July 21, 2016 ABSTRACT MicroRNA expression profiling assays have shown that miR-34b/c and miR-449a are down-regulated in nasopharyngeal carcinoma (NPC); however, the targets and functions of miR-34b/c and miR-449a in the pathologenesis of NPC remain elusive. In this study, we verified miR-34b/c and miR-449a were significantly reduced with the advance of NPC. Overexpression of miR-34b-3 and miR-449a suppressed the growth of NPC cells in culture and mouse tumor xenografts. Using tandem mass tags for quantitative labeling and LC-MS/MS analysis to investigate protein changes after restoring expression of miR-34b-3, 251 proteins were found to be down-regulated after miR-34b-3 transfection. Through 3 replicate experiments, we found that miR-34b-3 regulated the expression of 15 potential targeted genes mainly clustered in the key enzymes of glycolysis metabolism, including lactate dehydrogenase A (LDHA). Further investigation revealed that miR-34b-3 and miR-449a negatively regulated LDHA by binding to the 3’ untranslated regions of LDHA. Furthermore, LDHA overexpression rescued the miR-34b-3 and miR-449a induced tumor inhibition effect in CNE2 cells. In addition, miR-34b-3 and miR-449a suppressed LDH activity and reduced LD content, which were directly induced by downregulation of the LDHA. Our findings suggest that miR-34b-3 and miR-449a suppress the development of NPC through regulation of glycolysis via targeting LDHA and may be potential therapeutic targets for the treatment of NPC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.10761

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Li, H., Li, X., Ge, X., Jia, L., Zhang, Z., Fang, R., Yang, J., Liu, J., Peng, S., Zhou, M., Xiang, J., Zeng, Z., Zhou, W., Xiong, W., Xiao, G., Fang, L., Li, G.-Y., & Li, Z.
Venue
Oncotarget
Published
2016-07-21
Volume
7
Issue
34
Pages
54838-54851
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2501419018
Cited by
35
References
3
FWCI
2.67
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.